Minimization of HIV Infection among Nigerian Women through the Use of Microbicides: An Insight from Mathematical Modeling

Document Type : Original Paper

Authors

1 Department of Mathematics, Faculty of Science, University of Lagos, Lagos, Nigeria

2 Sikiru Adetona College of Education, Science and Technology, Omu-Ijebu, Nigeria

3 Department of Applied Sciences, Federal College of Dental Technology and Therapy, Enugu, Nigeria

Abstract

A recent report indicated that one hundred and thirty thousand Nigerians were lately infected with HIV with the majority of infections resulting from unguarded vaginal sex. About two-thirds of new HIV infections in adults exist in women. Male circumcision and male condoms limit the danger of HIV infection, but the adoption of these procedures is beyond the control of Nigerian women due to gender inequality and gender-based violence against women in the country. In an attempt to provide a mathematical framework to examine a potential female-controlled strategy of HIV acquisition in Nigeria, a mathematical model is modified and analyzed for the transmission of HIV by incorporating pre-exposure prophylaxis (PrEP) in the form of a microbicide. The solutions of the model are proved to be positive. The critical points of the model and the epidemic threshold known as the reproduction number are also derived. The restricted case of total compliance to the use of the microbicide is analyzed by proving the global stability of the disease-free equilibrium (DFE) of the model. The general case which permits individuals to default the microbicide is also investigated by proving the global stability of the endemic equilibrium (EE) of the model. Numerical simulation is carried out to verify the analytical results and the results of the simulation show that strict compliance and consistent use of the microbicide may tend HIV acquisition among Nigerian women to zero.

Keywords

Main Subjects

References

[1] Aderinto, Y.O., Iyasere, J.I., Yisa, B.M. and Ejieji, C.N., 2020. Mathematical model for an effective management of HIV infection with a view of window period. Daffodil International University Journal of Science and Technology, 15, pp. 21-25.
[2] Aljhani, S., Noorani, M. S. Md. and Alomari, A. K. 2020. Numerical solution of fractionalorder HIV model using homotopy method. Discrete Dynamics in Nature and Society, https://doi.org/10.1155/2020/2149037.
[3] Ayoade, A. A. and Ibrahim, M. O., 2022. Analysis of transmission dynamics and mitigation success of COVID-19 in Nigeria: an insight from a mathematical model. The Aligarh Bulletin of Mathematics, 41, pp. 81-106.
[4] Ayoade, A. A., Agboola, S. O. and Ibrahim, M. O., 2019. Mathematical analysis of the effect of maternal immunity on the global eradication of measles. Anale.Seria Informatica, 17, pp. 235-241.
[5] Ayoaade, A. A. and Thota, S., 2023. Functional education as a nexus between agricultural and industrial revolution: an epidemiological modeling approach. Uniciencia, 37, pp. 1-16. 
[6] Ayoade, A. A., Oyedepo, T. and Agunbiade, S., 2023. Mathematical modeling of Toxoplasma gondii between the environment and cat population under vaccination and sanitation. Journal of Fractional Calculus and Applications(JFCA), 14, pp. 75-87.
[7] Babayemi, O.O., Daniel, S. W., Sabastine, S.W., Tolulope, T.O. and Chamberline, E. O., 2018. Quantification of the effect of terrorism on the HIV response in Nigeria. The Lancet, 391, pp. 1257-1260.
[8] BBC New, 2017. Scientists say vaginal gel cuts HIV-infections by half. Retrieved February 7, 2022 from:        www.bbc.co.uk/news/health-10691353.
[9] Campos, C., Silva, C. J. and Torres, D. F. M., 2019. Numerical optimal control of HIV transmissionn octave/matlab. Math.  Comput. Appl., 25, pp. 1-20. doi:10.3390/mca25010001.
[10] CDC, 2020. Travelling? Make sure you protect yourself from malaria, Retrieved January 4, 2022 from: www.cdc.gov/malaria/resources/pdf/travelers.
[11] Etiaba, E., Onwujekwe, O., Torpey, K., Uzochukwu, B. and Chiegil, R. 2016. What is the economic burden of subsidized HIV/AIDS treatment services on patients in Nigeria and is this burden catastrophic to households?. Plos One, 11, e0167117.
[12] European Medicine Agency, 2015. First medicine for HIV pre-exposure prophylaxis recommended for approval in the EU. Retrieved September 5, 2022.
[13] Fagbamigbe, A. F., Adebayo, S. B. and Idemudia, E., 2016. Marital status and HIV prevalence among women in Nigeria: ingredients for evidence-based programming. International Journal of Infectious Diseases, 48, pp. 57-63.
[14] Ferrari, A. J., Lara, L. P., Olguin, M. C. and Santillan- Marcus, E. A., 2022. Comparative study of some numerical schemesfor a fractional order model of HIV infection treatment. Trends in Computational and Applied Mathematics, 23, pp. 607-623.
[15] Hernandez-Vargas, B. J. and Middleton, R. H., 2013. Modeling the three stages of HIV infection. Journal of Theoretical Biology, 320, pp. 33-40.
[16] Jawaz, M., Ahmed, N., Baleanu, D., Rafiq, M. and Rehman, M. A, 2020. Positivity preserving technique for the solution of HIV/AIDS reaction diffusion model with time delay. Frontier in Physics 7, pp. 1-10.
[17] Karim, Q. A., Karim, S. S. A., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E. et al., 2017. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women, Science, 329, pp. 1168-1174.
[18] Kerrigan, D. and Wirtz, A., 2016. The global HIV epidemics among sex workers. The World Bank publications.
[19] Kimber, A. R. and Oduwole, H. K., 2008. A mathematical model of HIV/AIDS transmission dynamics considering counseling and antiretroviral therapy, Journal of Modern Mathematics and Statistics, 2, pp. 166-169.
[20] Mesquita, P. M. M., Rastogi, R. , Segarra, T.J., Tella, G., Torres, R.S., Kiser, N.M. et al., 2016. Intra virginal ring delivery of tenofovirdisoproxi; fumerate for prevention of HIV and herpes simplex virus infection. J. Antimicrob. Chemother., 67, pp. 1730-1738.
[21] M. M. News, 2017. Tenofovir vaginal gel first microbicide to prevent HIV, HSV infections. Retrieved June 20, 2022 from: www.medscape.com/viewarticle/725583
[22] NAtional Agency for Control of AIDS, 2017. National Strategic Framework 2017-2012.
[23] Nsuami, M. U. and Witbooi, P., 2018. A model of HIV/AIDS population dynamics including ARV treatment and pre-exposure prophylaxis. Advances in Difference Equations, 11, pp. 1-12. doi: 10.1186/s13662-017-1458-x.
[24] Nyabadza, F. and Mukandavire, Z., 2011. Modelling HIV/AIDS in the presence of an HIV testing and screening campaign, Journal of Theoretical Biology, 280, pp. 167-179.
[25] Okosun, K. O., Makinde, O. D. and Takaida, I., 2013. Analysis of recruitment and industrial huma resources management for optimal productivity in the presence of HIV/AIDS epidemic. Journal of Biological Physics, 39, pp. 99-121.
[26] The Punch Nigeria (September 20, 2019). 10 000 living with HIV in Imo. Available online at punchng.com/10000-living-with-hiv-in-imo.
[27] Thota, S., Gemechu, T. and Ayoade, A. A., 2023. On new hybrid root-finding algorithms for solving transcendental equations using exponential and Halley’s method, Ural Mathematical Journal, 9(1), pp. 176-186. doi: 10.15826/umj.2023.1.016
[28] UNAIDS, 2018. Number of people living with HIV. Retrieved on May 1, 2022 from: http://aidsinfo.unaids.org.
[29] UNAIDS, 2017. West and Central Africa catch up plan.
[30] UNAIDS, 2019. HIV/AIDS epidemics in Nigeria. Retrieved on June 4, 2019 from: www.unaids.org/en/regionscountries/countries/nigeria.
[31] UNAIDS, 2019. Current success in HIV/AIDS fight in Nigeria.Retrieved on January 12, 2022 from: www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/ 2019/march/20190314nigeria
[32] UNAIDS, 2016. Prevention gap report. 
[33] UNAIDS, 2018. Start free, Stay free, AIDS free: 2017 progress report.
[34] UNAID Statement, 2007. Immunizations are discontinued in two HIV vaccines trials. Retrieved December 5, 2018 from: www.naid.nih.gov/news/newsreleases/2007/pages/stepstatement.aspx.
[35] WHO, 2018. WHO report on the global HIV trend. Retrieved on February 5, 2022, www.who.1nt/factsheet/detail.
[36] WHO, 2016. Microbicide. Available at: www.who.int/hiv/topics/microbicides/en.
[37] Williamson, T. R. and Rodd, J., 2016. Civil society advocacy in Nigeria: promoting democratic norms and donor demand?, BMC Int. Health Hum. Rights, 16, pp. 7-15.

Files

History

  • Receive Date: 29 October 2022
  • Revise Date: 14 February 2023
  • Accept Date: 18 July 2023

Share

How to cite

Statistics